Relationship of Serum Kallistatin Level With Arterial Stiffness and Metabolic Parameters in Obesity-Related Chronic Kidney Disease.

Alev MahserAli SerelGiray BozkayaBengu TatarErhan Tatar

Published in: Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation (2024)

Serum kallistatin levels increase in patients with obesity-related kidney disease. Especially hypertension and hyperuricemia are associated with an increase in serum kallistatin.

Keyphrases

chronic kidney disease
blood pressure
metabolic syndrome
insulin resistance
weight loss
type diabetes
weight gain
high fat diet induced
end stage renal disease
uric acid
body mass index
skeletal muscle
drug induced